The various regulatory agencies have expectations that pharmaceutical manufacturers will demonstrate control over their manufacturing equipment. The FDA’s findings of deficiencies concerning equipment validation indicate the agencies expect definitive evidence that the equipment qualification and validation schedules of a facility will satisfactorily control their manufacturing processes. Examples of FDA form 483 findings for equipment qualification and validation indicate deficiencies in many of these studies.
The cost of non-compliance is therefore more than that of compliance. Are you in compliance with the FDA regulations for equipment qualification and validation in your manufacturing facility?
In this webinar you will learn the different global agencies expectations of equipment qualification along with the development of a sound process validation program in order to develop and implement bulletproof solutions that are accepted, effective, and efficient. Through case study analysis we will examine best practices to provide thoughts and ideas to develop or improve the performance of your current system. Additionally, case studies will explore how your management practices of your equipment qualification/ validation and process validation programs can help or hurt your legal liability and the legal issues that arise from non-conformance with regulators and Auditors.
Course Objective:
Upon completing this course participants should:
Course Outline:
o Europe
o FDA
o Global harmonization and expectations
o Validation Policy
o Validation Master Plan (VMP)
o Documents Equipment Qualification
o SOPs
o Responsibilities
o Validation Team
o Presumption for Qualification/Validation
o Qualification Phases, DQ, IQ, OQ, PQ
o Qualification of existing systems and equipment
o Requalification/Validation
o SOPs
o Writing a qualification protocol, content
o Executing a qualification
o Tests, and data
o Documents
o Writing a qualification final report
o Questions
o SOPs
o Writing a Process validation protocol
o Content and execution
o SOPs
o Writing the validation plan
o Methodology and performance
o Report writing for method validation
o Presumption for validation
o Support of Equipment Qualification and Process Validation
o Quality Management System
o Risk Analysis
o Calibration/Maintenance
o Change Control
o Auditing equipment qualification and process validation
o External Equipment Qualification and process Validation
o Contract Manufacturer
o Qualification/Validation by a supplier
o Review of FDA warning letters
o Case Study Exercise from current FDA Warning Letters
o Theoretical Case exercises
o Questions
Target Audience:
This is a practical webinar designed to provide pharmaceutical, bio-pharmaceutical, biologics and medical device professionals with the information and tools they require to prepare for and manage an FDA inspection. The course is ideal for Managers, Directors, and Vice Presidents of Regulatory Affairs and Quality Assurance.
What You Get:
The various regulatory agencies have expectations that pharmaceutical manufacturers will demonstrate control over their manufacturing equipment. The FDA’s findings of deficiencies concerning equipment validation indicate the agencies expect definitive evidence that the equipment qualification and validation schedules of a facility will satisfactorily control their manufacturing processes. Examples of FDA form 483 findings for equipment qualification and validation indicate deficiencies in many of these studies.
The cost of non-compliance is therefore more than that of compliance. Are you in compliance with the FDA regulations for equipment qualification and validation in your manufacturing facility?
In this webinar you will learn the different global agencies expectations of equipment qualification along with the development of a sound process validation program in order to develop and implement bulletproof solutions that are accepted, effective, and efficient. Through case study analysis we will examine best practices to provide thoughts and ideas to develop or improve the performance of your current system. Additionally, case studies will explore how your management practices of your equipment qualification/ validation and process validation programs can help or hurt your legal liability and the legal issues that arise from non-conformance with regulators and Auditors.
Upon completing this course participants should:
This is a practical webinar designed to provide pharmaceutical, bio-pharmaceutical, biologics and medical device professionals with the information and tools they require to prepare for and manage an FDA inspection. The course is ideal for Managers, Directors, and Vice Presidents of Regulatory Affairs and Quality Assurance.
Getting Ready for an FDA Inspection
Get Instant Access 60 Minutes View Program |
QSR-Compliant Equipment Control & Validation of Processes in the Manufacturing Environment
Get Instant Access 90 Minutes View Program |
3 Hours Virtual Seminar: China Compliance Processes for Life Science Products: Company Establishment, Clinical Trials, Registrations, Renewals and Supply Chain Considerations
Get Instant Access 180 Minutes View Program |
6-hour Virtual Seminar - FDA’s New Stringent Import Requirements Concerning International Consequences by Ex-FDA Official
Get Instant Access 360 Minutes View Program |
6-hr Virtual Seminar: Understanding Corrective and Preventive Action in FDA- and ISO-Regulated Industry
Get Instant Access 360 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry